No Data
Third Quarter Report 2024
Huayu Pharmaceutical (688553.SH): The net income in the first three quarters was 0.227 billion yuan, a year-on-year increase of 155.62%.
Glory 10月25日丨Huiyu Pharmaceuticals (688553.SH) announced its third quarter report for 2024, with a company's revenue of 0.852 billion yuan in the first three quarters, a year-on-year increase of 29.24%; net income attributable to shareholders of the listed company was 0.227 billion yuan, a year-on-year increase of 155.62%; net profit attributable to shareholders of the listed company after deducting non-recurring losses was 0.1 billion yuan, a year-on-year increase of 141.81%; basic earnings per share was 0.54 yuan.
Express News | Huiyu Pharmaceutical: Net income in the third quarter increased by 701.17% year-on-year.
Express News | Huiyu Pharmaceutical: Acetylglutathione injection obtained pharmaceutical registration certificate.
Huiyu Pharmaceutical (688553.SH): 18.3979 million shares of restricted stocks will be unlocked on October 28th.
Gelonghui October 18th丨Huiyu Pharma (688553.SH) announced that the total number of stocks listed this time is 18.3979 million shares. The stock listing date is October 28, 2024. (As October 26, 2024 is a non-trading day, it will be postponed to the next trading day).
Huiyu Pharmaceuticals (688553.SH): The company's employees shareholding platform voluntarily commit not to reduce their shareholding in the company.
On October 18, Gelonhui announced that Huayu Pharmaceuticals (688553.SH) recently received the "Letter of Commitment not to reduce the company's shares voluntarily" issued by the company's employees holding platform controlled by the actual controller and controlling shareholder, Neijiang Hengce Enterprise Management Consulting Services Center (Limited Partnership) (hereinafter referred to as "Neijiang Hengce") and Neijiang Shengyu Enterprise Management Services Center (Limited Partnership) (hereinafter referred to as "Neijiang Shengyu"). Based on their confidence in the company's future development prospects and the recognition of its long-term investment value, the company's employee holding platforms Neijiang Hengce and Neijiang Shengyu voluntarily commit: starting from October 28, 2024, for the next 6 years.
No Data
No Data